FDA allows Amarin to market off-label use of Vascepa
Wednesday, March 9, 2016 - 12:50
in Mathematics & Economics
Stephen FellerBETHESDA, Md., March 9 (UPI) -- The FDA agreed to allow pharmaceutical company Amarin to promote off-label uses for its drug Vascepa not approved by the agency, according to the company.